Condensed Consolidated Interim Financial Statements as of June 30, 2018

Bayer Group
Consolidated Statements of Comprehensive Income

 

 

Q2 2017

 

Q2 2018

 

H1 2017

 

H1 2018

 

 

€ million

 

€ million

 

€ million

 

€ million

1

Total income and expense items (including reclassifications) that may not or must not be recognized through profit or loss according to other IFRS

Income after income taxes

 

1,477

 

805

 

3,748

 

2,759

of which attributable to noncontrolling interest

 

253

 

6

 

441

 

6

of which attributable to Bayer AG stockholders

 

1,224

 

799

 

3,307

 

2,753

Remeasurements of the net defined benefit liability for post-employment benefit plans

 

300

 

82

 

905

 

(94)

Income taxes

 

(132)

 

59

 

(327)

 

58

Other comprehensive income from remeasurements of the net defined benefit liability for post-employment benefit plans

 

168

 

141

 

578

 

(36)

Changes in fair values of equity instruments measured at fair value

 

 

90

 

 

185

Income taxes

 

 

(2)

 

 

(2)

Other comprehensive income from equity instruments measured at fair value

 

 

88

 

 

183

Other comprehensive income relating to associates accounted for using the equity method

 

 

17

 

 

4

Other comprehensive income that will not be reclassified subsequently to profit or loss

 

168

 

246

 

578

 

151

Changes in fair values of cash flow hedges

 

10

 

292

 

(78)

 

352

Reclassified to profit or loss

 

(27)

 

(26)

 

27

 

(57)

Reclassified to goodwill

 

 

(37)

 

 

(37)

Income taxes

 

8

 

(75)

 

23

 

(83)

Other comprehensive income from cash flow hedges

 

(9)

 

154

 

(28)

 

175

Changes in fair values of available-for-sale financial assets

 

(27)

 

 

(34)

 

Reclassified to profit or loss

 

 

 

 

Income taxes

 

(1)

 

 

8

 

Other comprehensive income from available-for-sale financial assets

 

(28)

 

 

(26)

 

Changes in exchange differences recognized on translation of operations outside the eurozone

 

(1,213)

 

1,021

 

(1,384)

 

639

Reclassified to profit or loss

 

 

 

 

Other comprehensive income from exchange differences

 

(1,213)

 

1,021

 

(1,384)

 

639

Other comprehensive income relating to associates accounted for using the equity method

 

40

 

3

 

47

 

2

Other comprehensive income that may be reclassified subsequently to profit or loss

 

(1,210)

 

1,178

 

(1,391)

 

816

Total other comprehensive income1

 

(1,042)

 

1,425

 

(813)

 

968

of which attributable to noncontrolling interest

 

(86)

 

(1)

 

(63)

 

(5)

of which attributable to Bayer AG stockholders

 

(956)

 

1,426

 

(750)

 

973

Total comprehensive income

 

435

 

2,230

 

2,935

 

3,727

of which attributable to noncontrolling interest

 

167

 

5

 

378

 

1

of which attributable to Bayer AG stockholders

 

268

 

2,225

 

2,557

 

3,726

Compare to Last Year